Cantor Fitzgerald Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR)

Equities research analysts at Cantor Fitzgerald began coverage on shares of Anteris Technologies Global (NASDAQ:AVR) in a research report issued on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $9.00 price target on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 59.86% from the stock’s current price.

Separately, Barclays assumed coverage on Anteris Technologies Global in a research note on Tuesday. They issued an “overweight” rating and a $22.00 price objective on the stock.

Anteris Technologies Global Price Performance

Shares of NASDAQ AVR opened at $5.63 on Tuesday. Anteris Technologies Global has a one year low of $5.10 and a one year high of $6.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.